Loading...

Cochlear Limited

CHEOF•PNK
Healthcare
Medical - Devices
$185.50
$0.00(0.00%)

Cochlear Limited (CHEOF) Stock Overview

Explore Cochlear Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.5/100

Key Financials

Market Cap12.1B
P/E Ratio52.11
EPS (TTM)$3.67
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Week$179.88
1 Month$173.75
3 Months$157.84
1 Year Target$233.76

CHEOF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cochlear Limited (CHEOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $233.76.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 52.11 and a market capitalization of 12.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
15.47%
↑ 15.47%
Profit Growth
$5.43
↑ 18.70%
EPS Growth
$5.43
↑ 19.04%
Operating Margin
21.70%
↑ 26.45%
ROE
19.70%
↑ 18.70%
Dividend Yield
0.00%
↑ 24.91%
Analyst Recommendations data is not available for CHEOFAnalyst Recommendations details for CHEOF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

CEO

Diggory William Howitt BE MBA

Employees

4,996

Headquarters

1 University Avenue, Sydney, NSW

Founded

2009

Frequently Asked Questions

;